Latest news with #Choksey
Economic Times
4 days ago
- Business
- Economic Times
Deven Choksey on 3 insurance stocks to invest in now
Deven Choksey, MD, DRChoksey FinServ Pvt. Ltd, says private sector insurance companies remain relatively more favourable from the growth perspective because their base is giving them an advantage at this point of time. Would Choksey immediately buy some of these stocks? The answer is both yes and no. Valuation-wise, some of them have already started scaling up. There is good potential in SBI and HDFC Life and also Bajaj Life from an investment perspective. ADVERTISEMENT Where do you see the insurance sector moving ahead and which are your top favourites? Deven Choksey: The private sector companies have been thriving on the product innovations, they have been thriving on the high value added product at the same time, and also adopting the digital approach in expanding the marketplace. The cost of acquiring a customer remains comparatively lower in their case. Given that situation, I think they deserve to be premium ranked which they are currently. The embedded value to EBITDA ratio that we look at in life insurance remains comfortably high for some of the private insurers compared to LIC. In my view, the growth momentum is expected to continue for a couple of reasons. One, the new income tax exemptions have started coming in this financial year, wherein the tax rates are not likely to apply till the amount of income is up to Rs 12 lakh and that is where the higher amount of surplus remaining in the hands of individuals would possibly find its way in some of the financial products including the life insurance. In this scenario, the private sector companies remain relatively more favourable from the growth perspective also because of the fact that their base is giving them an advantage at this point of time. Would we immediately buy some? The answer is yes and no both. Valuation-wise, some of them have already started scaling up. We find good potential in the likes of SBI and HDFC Life and also Bajaj Life Insurance business. We like those businesses from an investment perspective. What about the pharma sector? It has been steadily gaining market momentum, but I believe the market is not factoring in the big tariff overhang on pharma. What are you making of this space? Deven Choksey: That remains uncertain for sure, till the time we get full clarity on it. But leaving that aside, how are Indian companies strategizing their presence across the globe? On one hand, they are bringing out the specialty generics, the complex generics that some of the large companies like Sun Pharma, Cipla, Dr Reddy's among others are registering their presence in. The complex generics drugs are giving them the advantage of pricing power. As far as the pricing is concerned on this particular drug, because they are not competing with pure generic, that is a positive for them and most of these companies are expanding their portfolio on that side. The second positive which is going in is API business, which is again very comfortably getting merged into the formulation business some of the global peers, the large pharma companies, and again Indian companies including the likes of Divi's, Laurus, and even the other majors. Last but not the least, on the margin front, since the input cost scenario is improving, most of these pharma companies are seeing better margins in the current financial year vis-à-vis previous years. So, we remain distinctly confident about the prospects going forward despite the tariff turbulence. Once that is out of the way, some of these companies could get rerated. (You can now subscribe to our ETMarkets WhatsApp channel)
Economic Times
14-05-2025
- Business
- Economic Times
New lifetime high on cards for Nifty? Deven Choksey's market outlook amid rally
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel As the markets display resilience amid the recent geopolitical tensions, investors remain curious if the market will hit a fresh lifetime high in the current leg of the rally? As markets continue to surge amid positive momentum, Deven Choksey , MD of DRChoksey FinServ, in an interaction with ETNow, shared his perspective on where the indices could be headed next and the sectors likely to drive the market in the coming pointed out that the direction (of the market) remains positive despite the sharp rise in the previous session and suggested that a potential correction could present fresh buying opportunities for stated, "We probably would see the higher contribution into the index stocks, particularly from index stocks into the indexes," indicating that heavyweights in the IT sector may start providing a higher amount of push compared to the recent reliance on BFSI and Reliance noted the possibility of Nifty moving up to 25,200 in the near term and consolidating between the 24,200 to 25,200 range before making further moves. However, he cautioned that the money market would take some time to pull off and adjust to this particular rise, indicating that some amount of correction could be asked about stock recommendations given the current earnings season, Choksey maintained a cautious stance on midcaps and smallcaps, preferring to stay 'a little bit more protective' with a focus on larger identified IT, pharmaceuticals, and metals as sectors that could possibly give the momentum-based push to Nifty 50 stocks . Additionally, he expressed confidence in select BFSI stocks, highlighting their potential for a higher amount of growth driven by improving profit the broader market outlook , Choksey remarked that input costs in the manufacturing segment have remained under control unlike last year, while the demand scenario in capital goods has shown signs of improvement. This, he noted, could be a positive for manufacturing companies in the near response to a query about potential buys, Choksey did not specify a particular stock but mentioned that IT and pharma stocks, particularly those benefiting from the recent trade deal with China, are currently available at corrective price and could present attractive buying opportunities."I would consider buying into the portfolio now and not going for later," he added, indicating a selective and price-conscious approach in the current market environment.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Time of India
14-05-2025
- Business
- Time of India
New lifetime high on cards for Nifty? Deven Choksey's market outlook amid rally
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel As the markets display resilience amid the recent geopolitical tensions, investors remain curious if the market will hit a fresh lifetime high in the current leg of the rally? As markets continue to surge amid positive momentum, Deven Choksey , MD of DRChoksey FinServ, in an interaction with ETNow, shared his perspective on where the indices could be headed next and the sectors likely to drive the market in the coming pointed out that the direction (of the market) remains positive despite the sharp rise in the previous session and suggested that a potential correction could present fresh buying opportunities for stated, "We probably would see the higher contribution into the index stocks, particularly from index stocks into the indexes," indicating that heavyweights in the IT sector may start providing a higher amount of push compared to the recent reliance on BFSI and Reliance noted the possibility of Nifty moving up to 25,200 in the near term and consolidating between the 24,200 to 25,200 range before making further moves. However, he cautioned that the money market would take some time to pull off and adjust to this particular rise, indicating that some amount of correction could be asked about stock recommendations given the current earnings season, Choksey maintained a cautious stance on midcaps and smallcaps, preferring to stay 'a little bit more protective' with a focus on larger identified IT, pharmaceuticals, and metals as sectors that could possibly give the momentum-based push to Nifty 50 stocks . Additionally, he expressed confidence in select BFSI stocks, highlighting their potential for a higher amount of growth driven by improving profit the broader market outlook , Choksey remarked that input costs in the manufacturing segment have remained under control unlike last year, while the demand scenario in capital goods has shown signs of improvement. This, he noted, could be a positive for manufacturing companies in the near response to a query about potential buys, Choksey did not specify a particular stock but mentioned that IT and pharma stocks, particularly those benefiting from the recent trade deal with China, are currently available at corrective price and could present attractive buying opportunities."I would consider buying into the portfolio now and not going for later," he added, indicating a selective and price-conscious approach in the current market environment.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
